- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: LAS100977 1.25 μg
Total 1840 results
-
Aldeyra Therapeutics, Inc.Completed
-
Aldeyra Therapeutics, Inc.CompletedDry Eye | Dry Eye SyndromesUnited States
-
Aldeyra Therapeutics, Inc.CompletedAllergic ConjunctivitisCanada
-
University of NottinghamCompleted
-
Aldeyra Therapeutics, Inc.CompletedDry Eye SyndromesCanada
-
Comet Bio Inc.Biofortis, Merieux NutriSciencesUnknownGastrointestinal Tolerance
-
Aldeyra Therapeutics, Inc.RecruitingDry Eye DiseaseCanada
-
Aldeyra Therapeutics, Inc.Completed
-
University of WashingtonCompleted
-
Jiangxi Provincial Cancer HospitalCompleted
-
Almond Board of CaliforniaKGK Science Inc.CompletedHypercholesterolemia | HDL-CCanada
-
Translational Research Center for Medical Innovation...Kurosawa HospitalCompleted
-
PharmaMarApices Soluciones S.L.CompletedCOVID-19 InfectionSpain
-
Australian and New Zealand Intensive Care Research...CompletedCritical IllnessAustralia, New Zealand
-
Spanish Society of Critical Care Medicine and Coronary...RecruitingIntensive Care Unit Acquired WeaknessSpain
-
University of UtahGenentech, Inc.; Bavarian NordicWithdrawnProstate AdenocarcinomaUnited States
-
GTxCompletedProstate CancerUnited States
-
Penn State UniversityTerminated
-
Kang Stem Biotech Co., Ltd.RecruitingSafety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD) (smart(FURIN))Dermatitis, AtopicKorea, Republic of
-
Gulam ManjiGenentech, Inc.; Halozyme TherapeuticsTerminatedStudy Evaluating NEOadjuvant Immunotherapy in Resectable PANCreatic Ductal Adenocarcinoma (NEOiPANC)Pancreatic Ductal AdenocarcinomaUnited States
-
Penn State UniversityJenny Craig, Inc.Completed
-
Janssen Research & Development, LLCGenentech, Inc.CompletedCarcinoma, Non-Small-Cell LungFrance, United States, Spain, Hungary, Poland
-
University Hospital Hradec KraloveCompleted
-
Ake NorbergCompleted
-
Ohio State UniversityNatreon, Inc.Unknown
-
Bharat Serums and Vaccines LimitedActive, not recruitingFemale InfertilityIndia
-
AllerganCompleted
-
Astellas Pharma Global Development, Inc.Yale UniversityCompletedHealthy Volunteers | Pharmacokinetics of ASP3662 | Displacement of RadiotracerUnited States
-
University of ManitobaRecruitingPain, Postoperative | Liver Neoplasms | HepatectomyCanada
-
AstraZenecaCompletedAsthmaFrance, United Kingdom, Korea, Republic of, Argentina, Australia, Spain, Colombia
-
George Medicines PTY LimitedCompletedHypertensionAustralia, United States, United Kingdom, Poland, Sri Lanka, New Zealand, Czechia
-
NovartisCompletedMultiple SclerosisGreece, Russian Federation, Switzerland, Germany, Israel, Ireland, Belgium, Finland, United Kingdom, Netherlands, Canada, Romania, Hungary, Poland, Czech Republic, Australia, Estonia, France, Slovakia, South Africa, Sweden, Turkey
-
Mansoura UniversityRecruitingTransurethral Resection of ProstateEgypt
-
Merck Sharp & Dohme LLCCompleted
-
Sylentis, S.A.CompletedOcular Hypertension | Open Angle GlaucomaSpain, Germany, United States, Estonia
-
Organon and CoCompleted
-
Longbio PharmaRecruitingChronic Spontaneous UrticariaChina
-
Aldeyra Therapeutics, Inc.CompletedAllergic ConjunctivitisCanada
-
Guangdong Zhongsheng Pharmaceutical Co., Ltd.CompletedSolid Tumor | Idiopathic Pulmonary Fibrosis(IPF)China
-
Cubist Pharmaceuticals LLCCompleted
-
ActelionCompletedHealthy SubjectsFrance
-
Shahid Beheshti University of Medical SciencesUnknownDiabetic Macular EdemaIran, Islamic Republic of
-
Children's Hospital of PhiladelphiaTerminatedNeurofibromatosis Type 1 | Precancerous ConditionUnited States
-
Sun Yat-sen UniversityCompletedHyperparathyroidism | HypercalcemiaChina
-
AstraZenecaCompletedAsthma | Chronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Brazil, United Kingdom, Germany, Philippines, Denmark, Australia, Argentina, India, Belgium
-
Otsuka Pharmaceutical Co., Ltd.RecruitingMigraine DisordersJapan
-
Cancer Institute and Hospital, Chinese Academy...Active, not recruitingChemotherapy | Gastric Cancer Stage IV | Tislelizumab | First-lineChina
-
Hoffmann-La RocheCompletedProstatic Neoplasms, Castration-ResistantUnited States, Korea, Republic of, Belgium, United Kingdom, Canada, China, Denmark, France, Greece, Poland, Spain, Italy, Czechia, Japan, Switzerland, Australia, Germany, Austria, Hungary, Russian Federation, Taiwan